Your browser doesn't support javascript.
loading
Involvement of osteopontin, EpCAM, estrogen receptor-alpha, and carbonic anhydrase IX protein in managing lung cancer via Berberine-loaded liquid crystalline nanoparticles.
De Rubis, Gabriele; Paudel, Keshav Raj; Allam, Venkata Sita Rama Raju; Malyla, Vamshikrishna; Subramaniyan, Vetriselvan; Singh, Sachin Kumar; Panth, Nisha; Gupta, Gaurav; Hansbro, Philip Michael; Chellappan, Dinesh Kumar; Dua, Kamal.
Afiliación
  • De Rubis G; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, NSW 2007, Australia; Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, Australia.
  • Paudel KR; Centre of Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, NSW 2007, Australia.
  • Allam VSRR; Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden.
  • Malyla V; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, NSW 2007, Australia; Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, Australia; Centre of Inflammation, Centenary Institute an
  • Subramaniyan V; Pharmacology Unit, Jeffrey Cheah School of Medicineand Health Sciences, Monash University Malaysia, Jalan Lagoon Selatan, Bandar Sunway, 47500 Selangor Darul Ehsan, Malaysia.
  • Singh SK; Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, Australia; School of Pharmaceutical Sciences, Lovely Professional University, Jalandhar­Delhi G.T Road, Phagwara, Punjab, India.
  • Panth N; Centre of Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, NSW 2007, Australia.
  • Gupta G; Centre for Global Health Research, Saveetha Medical College, Saveetha Institute of Medical and Technical Sciences, Saveetha University, India; School of Pharmacy, Graphic Era Hill University, Dehradun 248007, India; School of Pharmacy, Suresh Gyan Vihar University, Jagatpura, 302017, Jaipur, India.
  • Hansbro PM; Centre of Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, NSW 2007, Australia.
  • Chellappan DK; Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil 57000, Kuala Lumpur, Malaysia. Electronic address: Dinesh_Kumar@imu.edu.my.
  • Dua K; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, NSW 2007, Australia; Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, Australia. Electronic address: Kamal.Dua@uts.edu.au.
Pathol Res Pract ; 253: 154971, 2024 Jan.
Article en En | MEDLINE | ID: mdl-38029714
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Berberina / Nanopartículas / Neoplasias Pulmonares / Neoplasias Límite: Humans Idioma: En Revista: Pathol Res Pract Año: 2024 Tipo del documento: Article País de afiliación: Australia Pais de publicación: Alemania
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Berberina / Nanopartículas / Neoplasias Pulmonares / Neoplasias Límite: Humans Idioma: En Revista: Pathol Res Pract Año: 2024 Tipo del documento: Article País de afiliación: Australia Pais de publicación: Alemania